Hepatic Disposition of the Acyl Glucuronide1-O-Gemfibrozil-β-d-Glucuronide: Effects of Dibromosulfophthalein on Membrane Transport and Aglycone Formation1

Abstract

The liver plays an important role in the disposition of acyl glucuronides by determining their extent of formation, biliary excretion, and efflux into blood. Thus, both intrahepatic and extrahepatic exposure to these reactive polar conjugates depends on the efficiency of hepatic transport mechanisms, which may be shared with other nonbile acid organic anions. Using the isolated perfused rat liver preparation, the hepatic disposition of the acyl glucuronide, 1-O-gemfibrozil-β-d-glucuronide, was examined in the presence of the organic anion dibromosulfophthalein (DBSP). Using a recirculating system, livers were perfused for 90 min with an erythrocyte-free perfusion medium containing 1% (w/v) albumin and 1-O-gemfibrozil-β-d-glucuronide (3 μM) alone (n = 6) or with DBSP (200 μM,n = 7). The glucuronide was avidly taken up by the liver, excreted into bile, and hydrolyzed within the liver to its aglycone, gemfibrozil. DBSP significantly (P < .05) lowered the conjugate’s mean hepatic clearance (8.98–5.17 ml/min), intrinsic clearance (44.0–17.7 ml/min), and fraction eliminated in bile (72.8–48.7% of the dose), while increasing perfusate gemfibrozil concentrations (0.52–0.92 μM at 90 min). Furthermore, DBSP significantly (P < .05) lowered the ratio of intrahepatic to unbound perfusate concentrations of 1-O-gemfibrozil-β-d-glucuronide (139.0–35.0) and showed a trend to lower the ratio of bile to intrahepatic concentrations (111.3–76.2, P = .05). Thus, the study demonstrated that DBSP inhibited both the sinusoidal uptake and canalicular transport of 1-O-gemfibrozil-β-d-glucuronide, suggesting that the hepatic membrane transport of acyl glucuronides is carrier mediated and shared with other organic anions.

Footnotes

  • Send reprint requests to: Dr. B.C. Sallustio, Department of Clinical Pharmacology, The Queen Elizabeth Hospital, 28 Woodville Rd. Woodville South 5011, South Australia.

  • 1 This study was supported in part by a University of South Australia Internal Research Development Grant and a National Health and Medical Research Foundation Grant. L.S. is funded by a Queen Elizabeth Hospital Postgraduate Research Scholarship.

  • Abbreviations:
    Agg(0–90)
    amount excreted in bile over 90 min
    AUC(0-∞)
    area under the perfusate concentration versus time curve from 0 to infinity
    AUC(0–90)
    area under the perfusate concentration versus time curve from 0 to 90 min
    Bgg
    fraction cleared unchanged by biliary excretion
    BSP
    bromosulfophthalein
    CL
    total clearance
    CLint
    intrinsic clearance
    D
    dose
    DBSP
    dibromosulfophthalein
    DNP-SG
    S-(2,4-dinitrophenyl)-glutathione
    fu
    fraction unbound in perfusate
    GG
    1-O-gemfibrozil-β-d-glucuronide
    • Received March 6, 1998.
    • Accepted August 7, 1998.
« Previous | Next Article »Table of Contents